Hiberix Haemophilus influenzae type b (Hib) vaccine available - MPR
Links shared publicly online about this topic.
- 1,689total visits
Hiberix Haemophilus influenzae type b (Hib) vaccine available - MPR
empr.com —
View full resource at empr.com
Tags: Vaccination, Flu, Tetanus, Disease and Condition, Vaccine, GlaxoSmithKline
Most Recently Shared on October 9, 2009 at 2:45 pm By:
MPR News: Hiberix Haemophilus influenzae type b (Hib) vaccine available: GlaxoSmithKline has launched .. http://bit.ly/CpMkB
Study Finds Shifting Disease Burden Following Universal Hib Vaccination - QualityPoint Technologies
qualitypointtech.net — “Vaccination against Haemophilus influenzae type b, or Hib, once the most common cause of bacterial meningitis in children, has dramatically reduced the incidence of Hib disease in young children over the past 20 years, according to a study published in Clinical Infectious Diseases and available online. However, other strains of the bacteria continue to cause substantial disease among the nation’s youngest and oldest age groups.” View full resource at qualitypointtech.net
Most Recently Shared on November 11, 2011 at 10:45 am By:
Study Finds Shifting Disease Burden Following Universal Hib Vaccination: Vaccination against Haemophilus influenza... http://t.co/sEl4NUZe
FDA Approves GSK's Hib Vaccine, Hiberix
drugs.com — “Hiberix (Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)) is used for active immunization against invasive disease caused by Haemophilus influenzae type b. Includes Hiberix side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 22, 2009 at 2:52 am By:
FDA Approves GSK's Hib Vaccine, Hiberix - http://bit.ly/p0qcf
GlaxoSmithKline's Hib vaccine obtains FDA approval - Related Stories - AAP SmartBrief
smartbrief.com — “GlaxoSmithKline gained accelerated FDA clearance for Hiberix, a vaccine against Haemophilus influenzae Type B, which causes diseases such as meningitis and pneumonia. The approval allows the drug to be used as a booster in children 15 months to 4 years old and is part of an effort to address a short” View full resource at smartbrief.com
Most Recently Shared on August 21, 2009 at 9:43 pm By:
Clara Song Doctor, Pediatrician, and Physician
GlaxoSmithKline's Hib vaccine obtains FDA approval http://sbne.ws/r/2BuB
FDA approves Hiberix Haemophilus influenzae type b vaccine
news-medical.net — “In response to a U.S. shortage of a vaccine to protect infants from Haemophilus influenzae type b (Hib), GlaxoSmithKline (NYSE: GSK) has received accelerated approval from the FDA (Food and Drug Administration) for Hiberix((R)) [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] as a booster dose in children 15 months through four years of age. Hib is an often severe and potentially deadly bacterial infection that can cause meningitis.” View full resource at news-medical.net
Most Recently Shared on August 20, 2009 at 2:06 am By:
Meningitis News: FDA approves Hiberix Haemophilus influenzae type b vaccine: In response to a U... http://bit.ly/iCn0k
Accelerated Approval of Hiberix to Help Sustain Adequate Vaccine Supply
fda.gov — “The U.S. Food and Drug Administration today approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.” View full resource at fda.gov
Most Recently Shared on August 19, 2009 at 10:12 pm By:
eyeonfda Pharma and Health Lawyer
FDA Accelerated Approval of GSK's Hiberix to Help Sustain Adequate Vaccine Supply http://bit.ly/3rZby
Advertisement
